Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model.

Cho EG, Zaremba JD, McKercher SR, Talantova M, Tu S, Masliah E, Chan SF, Nakanishi N, Terskikh A, Lipton SA.

PLoS One. 2011;6(8):e24027. doi: 10.1371/journal.pone.0024027. Epub 2011 Aug 25.

2.

Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells.

Li Z, McKercher SR, Cui J, Nie Z, Soussou W, Roberts AJ, Sallmen T, Lipton JH, Talantova M, Okamoto S, Lipton SA.

J Neurosci. 2008 Jun 25;28(26):6557-68. doi: 10.1523/JNEUROSCI.0134-08.2008.

3.

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A, Moore M, Osborn T, Cooper O, Spealman R, Hallett P, Isacson O.

Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.

4.

Survival and integration of neurons derived from human embryonic stem cells in MPTP-lesioned primates.

Wakeman DR, Weiss S, Sladek JR, Elsworth JD, Bauereis B, Leranth C, Hurley PJ, Roth RH, Redmond DE.

Cell Transplant. 2014;23(8):981-94. doi: 10.3727/096368913X664865. Epub 2013 Apr 2.

PMID:
23562290
5.

Induction of dopaminergic neuronal-like cells from CD44+ human amniotic fluids that are ameliorative to behavioral recovery in a Parkinson's disease rat model.

Liu T, Guo L, Liu Z, Huang Y, Cheng W.

Int J Mol Med. 2011 Nov;28(5):745-52. doi: 10.3892/ijmm.2011.732. Epub 2011 Jun 27.

PMID:
21720700
6.

Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.

Sánchez-Danés A, Consiglio A, Richaud Y, Rodríguez-Pizà I, Dehay B, Edel M, Bové J, Memo M, Vila M, Raya A, Izpisua Belmonte JC.

Hum Gene Ther. 2012 Jan;23(1):56-69. doi: 10.1089/hum.2011.054. Epub 2011 Nov 17.

7.

Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.

Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.

Brain. 2010 Jan;133(Pt 1):189-204. doi: 10.1093/brain/awp290. Epub 2009 Dec 7.

PMID:
19995872
8.

Comparative study of efficacy of dopaminergic neuron differentiation between embryonic stem cell and protein-based induced pluripotent stem cell.

Kwon YW, Chung YJ, Kim J, Lee HJ, Park J, Roh TY, Cho HJ, Yoon CH, Koo BK, Kim HS.

PLoS One. 2014 Jan 22;9(1):e85736. doi: 10.1371/journal.pone.0085736. eCollection 2014.

9.

Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization.

Stephens AS, Stephens SR, Hobbs C, Hutmacher DW, Bacic-Welsh D, Woodruff MA, Morrison NA.

J Biol Chem. 2011 Aug 26;286(34):30071-86. doi: 10.1074/jbc.M111.253518. Epub 2011 Jun 7.

10.

Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.

Chang YL, Chen SJ, Kao CL, Hung SC, Ding DC, Yu CC, Chen YJ, Ku HH, Lin CP, Lee KH, Chen YC, Wang JJ, Hsu CC, Chen LK, Li HY, Chiou SH.

Cell Transplant. 2012;21(1):313-32. doi: 10.3727/096368911X580572. Epub 2011 Jun 7.

PMID:
21669041
11.

Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo.

Li H, Radford JC, Ragusa MJ, Shea KL, McKercher SR, Zaremba JD, Soussou W, Nie Z, Kang YJ, Nakanishi N, Okamoto S, Roberts AJ, Schwarz JJ, Lipton SA.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9397-402. doi: 10.1073/pnas.0802876105. Epub 2008 Jul 1.

12.

One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons.

Geeta R, Ramnath RL, Rao HS, Chandra V.

Biochem Biophys Res Commun. 2008 Aug 22;373(2):258-64. doi: 10.1016/j.bbrc.2008.06.022. Epub 2008 Jun 17.

PMID:
18565328
13.

A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells.

Axell MZ, Zlateva S, Curtis M.

J Neurosci Methods. 2009 Nov 15;184(2):275-84. doi: 10.1016/j.jneumeth.2009.08.015. Epub 2009 Aug 26.

PMID:
19715727
14.

The co-transduction of Nurr1 and Brn4 genes induces the differentiation of neural stem cells into dopaminergic neurons.

Tan XF, Jin GH, Tian ML, Qin JB, Zhang L, Zhu HX, Li HM.

Cell Biol Int. 2011 Dec;35(12):1217-23. doi: 10.1042/CBI20110028.

PMID:
21663595
15.

Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue.

Sundberg M, Andersson PH, Åkesson E, Odeberg J, Holmberg L, Inzunza J, Falci S, Öhman J, Suuronen R, Skottman H, Lehtimäki K, Hovatta O, Narkilahti S, Sundström E.

Cell Transplant. 2011;20(2):177-91. doi: 10.3727/096368910X527266. Epub 2010 Sep 27.

PMID:
20875224
16.

Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons.

Freed WJ, Chen J, Bäckman CM, Schwartz CM, Vazin T, Cai J, Spivak CE, Lupica CR, Rao MS, Zeng X.

PLoS One. 2008 Jan 9;3(1):e1422. doi: 10.1371/journal.pone.0001422.

17.

Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.

Han F, Wang W, Chen B, Chen C, Li S, Lu X, Duan J, Zhang Y, Zhang YA, Guo W, Li G.

Cytotherapy. 2015 May;17(5):665-79. doi: 10.1016/j.jcyt.2015.02.001. Epub 2015 Mar 5.

PMID:
25747741
18.

Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells.

Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS, Kang SM, Lee H, Kim MH, Kim JH, Leem JW, Oh SK, Choi YM, Hwang DY, Chang JW, Kim DW.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3392-7. doi: 10.1073/pnas.0712359105. Epub 2008 Feb 27.

19.

Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.

Wang X, Lu Y, Zhang H, Wang K, He Q, Wang Y, Liu X, Li L, Wang X.

Int J Dev Neurosci. 2004 Jun;22(4):175-83.

PMID:
15245752
20.

Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.

Gu S, Huang H, Bi J, Yao Y, Wen T.

Brain Res. 2009 Feb 27;1257:1-9. doi: 10.1016/j.brainres.2008.12.016. Epub 2008 Dec 16.

PMID:
19111525

Supplemental Content

Support Center